Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The proposed rule could give millions of Americans access to the new drugs; it would also put pressure on the federal budget.
A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respecto
El presidente electo Donald Trump está listo para nominar a Robert F. Kennedy Jr. para que lidere el Departamento de Salud y Servicios Humanos, donde tendría un poder limitado sobre los medicamentos.
Dr Martin Makary Chosen to Head the FDA
A frequent Fox News commentator, Dr. Makary has a penchant for challenging the medical establishment, and stirred pandemic concerns with his views on Covid immunity and vaccine mandates.
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Know
President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, where he would have limited power over drugs.
F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labels
The drug, known by the brand name Klonopin, is used for panic disorder and seizures.
The New York Times Presents: ‘Weight of the World’ on Ozempic’s Rise
As GLP-1 medications like Ozempic soar in popularity, our new documentary follows three people on their weight-loss journeys — and explores how decades of diet culture paved the way for the drugs’ rise.
Trump’s New Pick for Attorney General, and a Surprise Turn in U.S. Drug Deaths
Plus, a “Wicked” warning.
Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Election
Some women are stocking up on the medications, saying they are concerned that the new administration could take steps to restrict access.
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma
Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claims
President-elect Donald J. Trump’s pick for health secretary opposes fluoride in water, promotes unproven Covid therapies and has threatened to prosecute medical journals.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.